Corrigendum: Cross-resistance among sequential cancer therapeutics: An emerging issue

• Rossella Loria,
• Patrizia Vici,
• Francesca Sofia Di Lisa,
• Francesca Sofia Di Lisa,
• Silvia Soddu,
• Marcello Maugeri-Saccà,
• Giulia Bon

Affiliations

Rossella Loria

Cellular Network and Molecular Therapeutic Target Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy

Patrizia Vici

Unit of Phase IV Trials, IRCCS Regina Elena National Cancer Institute, Rome, Italy

Francesca Sofia Di Lisa

Unit of Phase IV Trials, IRCCS Regina Elena National Cancer Institute, Rome, Italy

Francesca Sofia Di Lisa

Medical Oncology A, Department of Radiological, Oncological, and Anatomo-Pathological Sciences, Umberto I University Hospital, University Sapienza, Rome, Italy

Silvia Soddu

Cellular Network and Molecular Therapeutic Target Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy

Marcello Maugeri-Saccà

Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy

Giulia Bon

Cellular Network and Molecular Therapeutic Target Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy